Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues (Q37633402)

21 August 2017

1 reference

title

Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues (English)

1 reference

21 August 2017

4

Otto C Boerman

1 reference

21 August 2017

Edgar J Rolleman

1

1 reference

21 August 2017

Marleen Melis

2

1 reference

21 August 2017

Roelf Valkema

3

1 reference

21 August 2017

Eric P Krenning

5

1 reference

21 August 2017

Marion de Jong

6

1 reference

21 August 2017

14 November 2009

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

21 August 2017

1 reference

21 August 2017

37

1 reference

21 August 2017

5

1 reference

21 August 2017

1018-1031

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-009-1282-y

21 August 2017

0 references

cites work

Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study

1 reference

https://api.crossref.org/works/10.1007%2FS00259-009-1282-Y

86Y-DOTA0)-D-Phe1-Tyr3-octreotide (SMT487)--a phase 1 clinical study: pharmacokinetics, biodistribution and renal protective effect of different regimens of amino acid co-infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-009-1282-Y

A comparison of (111)In-DOTATOC and (111)In-DOTATATE: biodistribution and dosimetry in the same patients with metastatic neuroendocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-009-1282-Y

Repair of sublethal radiation injury after multiple small doses in mouse kidney: an estimate of flexure dose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-009-1282-Y

Amino acid infusion blocks renal tubular uptake of an indium-labelled somatostatin analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-009-1282-Y

Captopril to mitigate chronic renal failure after hematopoietic stem cell transplantation: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-009-1282-Y

Mitigation of radiation nephropathy after internal alpha-particle irradiation of kidneys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-009-1282-Y

In vivo radionuclide uptake quantification using a multi-pinhole SPECT system to predict renal function in small animals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-009-1282-Y

Studies on renal tubular protein reabsorption: Partial and near complete inhibition by certain amino acids

21 January 2018

1 reference

12 December 2020

Life-threatening hyperkalemia induced by arginine

1 reference

12 December 2020

Prevention of radiation-induced nephropathy and fibrosis in a model of bone marrow transplant by an angiotensin II receptor blocker

1 reference

12 December 2020

Tumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq (90)Y-DOTATOC.

1 reference

12 December 2020

Long-term follow-up of renal function after peptide receptor radiation therapy with (90)Y-DOTA(0),Tyr(3)-octreotide and (177)Lu-DOTA(0), Tyr(3)-octreotate

1 reference

12 December 2020

End-stage renal disease after treatment with 90Y-DOTATOC.

1 reference

12 December 2020

Renal accumulation of [111In]DOTATOC in rats: influence of inhibitors of the organic ion transport and diuretics

1 reference

12 December 2020

Renal tubulointerstitial changes after internal irradiation with alpha-particle-emitting actinium daughters

1 reference

12 December 2020

The risk of pronounced hyperkalaemia after arginine infusion in the diabetic subject

1 reference

12 December 2020

Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours.

1 reference

12 December 2020

Long-term efficacy of high-activity 111in-pentetreotide therapy in patients with disseminated neuroendocrine tumors

1 reference

12 December 2020

Evaluation of unusual neuroendocrine tumours by means of 68Ga-DOTA-NOC PET.

1 reference

12 December 2020

Acute hyperkalemia associated with intravenous epsilon-aminocaproic acid therapy

1 reference

12 December 2020

Long-term toxicity of [(177)Lu-DOTA (0),Tyr (3)]octreotate in rats

1 reference

12 December 2020

Reducing renal uptake of radiolabeled peptides using albumin fragments

1 reference

12 December 2020

Candidates for peptide receptor radiotherapy today and in the future.

1 reference

12 December 2020

Renal filtration, transport, and metabolism of low-molecular-weight proteins: A review

1 reference

12 December 2020

Nephrotoxicity of lysine and of a single dose of aminoglycoside in rats given lysine

1 reference

12 December 2020

In vitro detection of somatostatin receptors in human tumors

1 reference

12 December 2020

Mechanisms of lysine-induced acute renal failure in rats.

1 reference

12 December 2020

A new cause of renal thrombotic microangiopathy: yttrium 90-DOTATOC internal radiotherapy

1 reference

12 December 2020

Inhibition of renal uptake of indium-111-DTPA-octreotide in vivo

1 reference

12 December 2020

Progressive development of radiation damage in mouse kidneys and the consequences for reirradiation tolerance

1 reference

12 December 2020

Relevance of external beam dose-response relationships to kidney toxicity associated with radionuclide therapy

1 reference

12 December 2020

Biokinetics and dosimetry in patients administered with (111)In-DOTA-Tyr(3)-octreotide: implications for internal radiotherapy with (90)Y-DOTATOC

1 reference

12 December 2020

Toxicity and dosimetry of (177)Lu-DOTA-Y3-octreotate in a rat model.

1 reference

12 December 2020

Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives

1 reference

12 December 2020

Is the Renal Dosimetry for [90Y-DOTA0, Tyr3]Octreotide Accurate Enough to Predict Thresholds for Individual Patients?

1 reference

12 December 2020

Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC: relevance of kidney volume and dose rate in finding a dose-effect relationship

1 reference

12 December 2020

68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT

1 reference

12 December 2020

Molecular imaging of reduced renal uptake of radiolabelled [DOTA0,Tyr3]octreotate by the combination of lysine and Gelofusine in rats.

1 reference

12 December 2020

Angiotensin II receptor antagonists in the treatment and prevention of radiation nephropathy

1 reference

12 December 2020

A systematic review of the comparative safety of colloids

1 reference

12 December 2020

DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals

1 reference

12 December 2020

Arginine-induced hypophosphatemia and hyperkaliemia in man

1 reference

12 December 2020

[(111)In]DOTATOC as a dosimetric substitute for kidney dosimetry during [(90)Y]DOTATOC therapy: results and evaluation of a combined gamma camera/probe approach.

1 reference

12 December 2020

Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival

1 reference

12 December 2020

Internalisation of isotope-coupled somatostatin analogues

1 reference

12 December 2020

Megalin and cubilin, role in proximal tubule function and during development

1 reference

12 December 2020

Inhomogeneous localization of radioactivity in the human kidney after injection of [(111)In-DTPA]octreotide.

1 reference

12 December 2020

Update: improvement strategies for peptide receptor scintigraphy and radionuclide therapy

1 reference

12 December 2020

Radiation dose distribution in human kidneys by octreotides in peptide receptor radionuclide therapy

1 reference

12 December 2020

Inhibition of kidney uptake of radiolabeled somatostatin analogs: amino acids or gelofusine?

1 reference

12 December 2020

Quality of life in patients with gastroenteropancreatic tumors treated with [177Lu-DOTA0,Tyr3]octreotate

1 reference

12 December 2020

Phase I study of peptide receptor radionuclide therapy with [In-DTPA]octreotide: the Rotterdam experience

1 reference

12 December 2020

Survival and response after peptide receptor radionuclide therapy with [90Y-DOTA0,Tyr3]octreotide in patients with advanced gastroenteropancreatic neuroendocrine tumors

1 reference

12 December 2020

Renal uptake of radiolabeled octreotide in human subjects is efficiently inhibited by succinylated gelatin.

1 reference

12 December 2020

RENAL TOXICITY OF MALEIC ACID IN THE RAT: ENZYMATIC AND MORPHOLOGIC OBSERVATIONS

1 reference

12 December 2020

Somatostatin receptor subtype 2-mediated uptake of radiolabelled somatostatin analogues in the human kidney

1 reference

12 December 2020

Indium-111-pentetreotide prolongs survival in gastroenteropancreatic malignancies

1 reference

12 December 2020

Preliminary data on biodistribution and dosimetry for therapy planning of somatostatin receptor positive tumours: comparison of (86)Y-DOTATOC and (111)In-DTPA-octreotide

1 reference

12 December 2020

The gelatin-derived plasma substitute Gelofusine causes low-molecular-weight proteinuria by decreasing tubular protein reabsorption

1 reference

12 December 2020

Improved survival from acute renal failure after treatment with intravenous essential L-amino acids and glucose. Results of a prospective, double-blind study

1 reference

12 December 2020

Between the Scylla and Charybdis of peptide radionuclide therapy: hitting the tumor and saving the kidney

1 reference

12 December 2020

Results of individual patient dosimetry in peptide receptor radionuclide therapy with 177Lu DOTA-TATE and 177Lu DOTA-NOC.

1 reference

12 December 2020

Indium-111-diethylenetriaminepentaacetic acid-octreotide is delivered in vivo to pancreatic, tumor cell, renal, and hepatocyte lysosomes.

1 reference

12 December 2020

Dosimetry in Peptide radionuclide receptor therapy: a review.

1 reference

12 December 2020

Internalization of radiolabelled [DTPA0]octreotide and [DOTA0,Tyr3]octreotide: peptides for somatostatin receptor-targeted scintigraphy and radionuclide therapy

1 reference

12 December 2020

Megalin is essential for renal proximal tubule reabsorption of (111)In-DTPA-octreotide.

1 reference

12 December 2020

Chemical radioprotection: a critical review of amifostine as a cytoprotector in radiotherapy.

1 reference

12 December 2020

Amifostine: the preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies.

1 reference

12 December 2020

Amifostine protects rat kidneys during peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate.

1 reference

12 December 2020

Segmental expression of somatostatin receptor subtypes sst(1) and sst(2) in tubules and glomeruli of human kidney.

1 reference

12 December 2020

Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists.

1 reference

12 December 2020

Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.

1 reference

12 December 2020

Radiotherapy with a radiolabeled somatostatin analogue, [111In-DTPA-D-Phe1]-octreotide. A case history

1 reference

12 December 2020

Radiation nephropathy after radiotherapy in metastatic medullary thyroid carcinoma

1 reference

12 December 2020

Tolerance of normal tissue to therapeutic irradiation

1 reference

12 December 2020

Yttrium-90 DOTATOC: first clinical results

1 reference

12 December 2020

Proximal tubular necrosis associated with maleic acid administration to the rat

1 reference

12 December 2020

Successful brief captopril treatment in experimental radiation nephropathy

1 reference

12 December 2020

Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin

1 reference

12 December 2020

Brief pharmacological intervention in experimental radiation nephropathy

1 reference

12 December 2020

Radiation nephropathy after bone marrow transplantation

1 reference

12 December 2020

Renal uptake and retention of radiolabeled somatostatin, bombesin, neurotensin, minigastrin and CCK analogues: species and gender differences.

1 reference

12 December 2020

Gelatin-based plasma expander effectively reduces renal uptake of 111In-octreotide in mice and rats.

1 reference

12 December 2020

Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: present status, future prospects and limitations

1 reference

12 December 2020

Comparison of [(177)Lu-DOTA(0),Tyr(3)]octreotate and [(177)Lu-DOTA(0),Tyr(3)]octreotide: which peptide is preferable for PRRT?

1 reference

12 December 2020

Treatment with 177Lu-DOTATOC of patients with relapse of neuroendocrine tumors after treatment with 90Y-DOTATOC.

1 reference

12 December 2020

Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET/CT.

1 reference

12 December 2020

Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use

1 reference

12 December 2020

Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors

1 reference

12 December 2020

Hyperkalaemia during infusion of hyperosmolar amino acid solutions enriched with branched chain amino acids. Report of two cases

1 reference

12 December 2020

Internalization of indium-111 into human neuroendocrine tumor cells after incubation with indium-111-DTPA-D-Phe1-octreotide

1 reference

12 December 2020

Endocytosis and lysosomal hydrolysis of proteins in proximal tubules

1 reference

12 December 2020

Changing role of somatostatin receptor targeted drugs in NET: Nuclear Medicine's view.

1 reference

12 December 2020

Practical dosimetry of peptide receptor radionuclide therapy with (90)Y-labeled somatostatin analogs.

1 reference

12 December 2020

Low concentrations of intravenous polygelines promote low-molecular weight proteinuria

1 reference

12 December 2020

D-lysine reduction of indium-111 octreotide and yttrium-90 octreotide renal uptake

1 reference

12 December 2020

Receptor-mediated radiotherapy with Y-DOTA-DPhe-Tyr-octreotide: the experience of the European Institute of Oncology Group

1 reference

12 December 2020

Receptor-mediated radionuclide therapy with 90Y-DOTA-D-Phe1-Tyr3-Octreotide: preliminary report in cancer patients

1 reference

12 December 2020

Evaluating the clinical effectiveness of 90Y-SMT 487 in patients with neuroendocrine tumors.

1 reference

12 December 2020

Human kidney as target for somatostatin: high affinity receptors in tubules and vasa recta

1 reference

12 December 2020

Receptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotide

1 reference

12 December 2020

Indication for different mechanisms of kidney uptake of radiolabeled peptides.

1 reference

12 December 2020

A stylized computational model of the rat for organ dosimetry in support of preclinical evaluations of peptide receptor radionuclide therapy with (90)Y, (111)In, or (177)Lu.

1 reference

12 December 2020

Uptake of [111In-DTPA0]octreotide in the rat kidney is inhibited by colchicine and not by fructose

1 reference

12 December 2020

Effects of lysine and other amino acids on kidney structure and function in the rat.

1 reference

12 December 2020

Radiation nephropathy

1 reference

12 December 2020

Localisation and mechanism of renal retention of radiolabelled somatostatin analogues

1 reference

12 December 2020

Endocytosis of the somatostatin analogue, octreotide, by the proximal tubule-derived opossum kidney (OK) cell line.

1 reference

12 December 2020

New pansomatostatin ligands and their chelated versions: affinity profile, agonist activity, internalization, and tumor targeting

1 reference

12 December 2020

Dose-response effect of Gelofusine on renal uptake and retention of radiolabelled octreotate in rats with CA20948 tumours

1 reference

12 December 2020

Receptor PET/CT imaging of neuroendocrine tumors.

1 reference

12 December 2020

Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginine

1 reference

12 December 2020

Chymase is upregulated in diabetic nephropathy: implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease

1 reference

12 December 2020

Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors.

1 reference

12 December 2020

10.1007/S00259-009-1282-Y

Identifiers

DOI

1 reference

21 August 2017

1 reference